Welcome, Guest
Username: Password: Remember me

Profile for Protection, Effectiveness, along with Pharmacokinetics associated with Almonertinib (HS-10296) in Pretreated Sufferers Along with EGFR-Mutated Innovative NSCLC: A new Multicenter, Open-label, Stage One particular Trial. (brawave62)

brawave62's Avatar
  • OFFLINE
  • Rank: Fresh Boarder
  • Register Date: 19 Jan 2024
  • Last Visit Date: 19 Jan 2024
  • Time Zone: GMT +2:00
  • Local Time: 09:32
  • Profile Views: 16
  • Karma: 0
  • Location: Unknown
  • Gender: Unknown
  • Birthdate: Unknown

Signature

Posts

Recent Posts

No Posts
Time to create page: 0.321 seconds
Go to top